The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
Open accessAbstract
Purpose: The optimal regimen intensity before allogeneic hematopoietic cell transplantation (HCT) is unknown. We hypothesized that lower treatment-related mortality (TRM) with reduced-intensity conditioning (RIC) would result in improved overall survival (OS) compared with myeloablative conditioning (MAC). To test this hypothesis, we performed a phase III randomized trial comparing MAC with RIC in patients with acute myeloid leukemia or myelodysplastic syndromes. Patients and Methods: Patients age 18 to 65 years with HCT comorbidity index ≤ 4 and < 5% marrow myeloblasts pre-HCT were randomly assigned to receive MAC (n = 135) or RIC (n = 137) followed by HCT from HLA-matched related or unrelated donors. The primary end point was OS 18 months post–random assignment based on an intent-to-treat analysis. Secondary end points included relapse-free survival (RFS) and TRM. Results: Planned enrollment was 356 patients; accrual ceased at 272 because of high relapse incidence with RIC versus MAC (48.3%; 95% CI, 39.6% to 56.4% and 13.5%; 95% CI, 8.3% to 19.8%, respectively; P < .001). At 18 months, OS for patients in the RIC arm was 67.7% (95% CI, 59.1% to 74.9%) versus 77.5% (95% CI, 69.4% to 83.7%) for those in the MAC arm (difference, 9.8%; 95% CI, −0.8% to 20.3%; P = .07). TRM with RIC was 4.4% (95% CI, 1.8% to 8.9%) versus 15.8% (95% CI, 10.2% to 22.5%) with MAC ( P = .002). RFS with RIC was 47.3% (95% CI, 38.7% to 55.4%) versus 67.8% (95% CI, 59.1% to 75%) with MAC ( P < .01). Conclusion: OS was higher with MAC, but this was not statistically significant. RIC resulted in lower TRM but higher relapse rates compared with MAC, with a statistically significant advantage in RFS with MAC. These data support the use of MAC as the standard of care for fit patients with acute myeloid leukemia or myelodysplastic syndromes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
Vardiman, J. W., Thiele, J., Arber, D. A., Brunning, R. D., Borowitz, M. J., Porwit, A., Harris, N. L., Le Beau, M. M., Hellström-Lindberg, E., Tefferi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209262 · Cited by 4,424
Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., et al. (1998) · Blood · doi:10.1182/blood.v91.3.756 · Cited by 2,071
Slovak, M. L., Kopecky, K. J., Cassileth, P. A., Harrington, D. H., Theil, K. S., Mohamed, A., Paietta, E., Willman, C. L., Head, D. R., Rowe, J. M., et al. (2000) · Blood · doi:10.1182/blood.v96.13.4075 · Cited by 1,601
Cheson, B. D. (2006) · Blood · doi:10.1182/blood-2005-10-4149 · Cited by 1,580
McSweeney, P. A., Niederwieser, D., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,389
Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondón, G., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., et al. (1997) · Blood · doi:10.1182/blood.v89.12.4531 · Cited by 1,138
Self-citationMielcarek, M., Martin, P. J., Leisenring, W., Flowers, M. E. D., Maloney, D. G., Sandmaier, B. M., Maris, M. B., & Storb, R. (2003) · Blood · doi:10.1182/blood-2002-08-2628 · Cited by 562
Aoudjhane, M., Labopin, M., Gorin, N. C., Shimoni, A., Ruutu, T., Kolb, H.-J., Frassoni, F., Boiron, J. M., Yin, J. L., Finke, J., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403967 · Cited by 459
Baron, F., Maris, M. B., Sandmaier, B. M., Storer, B. E., Sorror, M., Diaconescu, R., Woolfrey, A. E., Chauncey, T. R., Flowers, M. E. D., Mielcarek, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.136 · Cited by 333
Protective Conditioning for Acute Graft-versus-Host Disease
Lowsky, R., Takahashi, T., Liu, Y. P., Dejbakhsh-Jones, S., Grumet, F. C., Shizuru, J. A., Laport, G. G., Stockerl-Goldstein, K. E., Johnston, L. J., Hoppe, R. T., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050642 · Cited by 331
Sorror, M. L., Giralt, S., Sandmaier, B. M., De Lima, M., Shahjahan, M., Maloney, D. G., Deeg, H. J., Appelbaum, F. R., Storer, B., & Storb, R. (2007) · Blood · doi:10.1182/blood-2007-06-096966 · Cited by 326
Self-citationBornhäuser, M., Kienast, J., Trenschel, R., Burchert, A., Hegenbart, U., Stadler, M., Baurmann, H., Schäfer-Eckart, K., Holler, E., Kröger, N., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70349-2 · Cited by 274
Ringdén, O., Labopin, M., Ehninger, G., Niederwieser, D., Olsson, R., Basara, N., Finke, J., Schwerdtfeger, R., Eder, M., Bunjes, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9692 · Cited by 271
Scott, B. L., Sandmaier, B. M., Storer, B., Maris, M. B., Sorror, M. L., Maloney, D. G., Chauncey, T. R., Storb, R., & Deeg, H. J. (2006) · Leukemia · doi:10.1038/sj.leu.2404010 · Cited by 235
Self-citationWalter, R. B., Gyurkocza, B., Storer, B. E., Godwin, C. D., Pagel, J. M., Buckley, S. A., Sorror, M. L., Wood, B. L., Storb, R., Appelbaum, F. R., et al. (2015) · Leukemia · doi:10.1038/leu.2014.173 · Cited by 216
Gyurkocza, B., Storb, R., Storer, B. E., Chauncey, T. R., Lange, T., Shizuru, J. A., Langston, A. A., Pulsipher, M. A., Bredeson, C. N., Maziarz, R. T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1460 · Cited by 210
Self-citationAlyea, E. P., Kim, H. T., Ho, V., Cutler, C., DeAngelo, D. J., Stone, R., Ritz, J., Antin, J. H., & Soiffer, R. J. (2006) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2006.06.003 · Cited by 186
Self-citationMartino, R., Caballero, M. D., Pérez Simón, J. A., Canals, C., Solano, C., Urbano-Ispı́zua, A., Bargay, J., Léon, A., Sarrá, J., Sanz, G. F., et al. (2002) · Blood · doi:10.1182/blood-2002-02-0400 · Cited by 178
Deeg, H. J., Scott, B. L., Fang, M., Shulman, H. M., Gyurkocza, B., Myerson, D., Pagel, J. M., Platzbecker, U., Ramakrishnan, A., Radich, J. P., et al. (2012) · Blood · doi:10.1182/blood-2012-04-423046 · Cited by 155
Self-citationA Scheme for Defining Cause of Death and Its Application in the T Cell Depletion Trial
Copelan, E. A., Casper, J. T., Carter, S. L., van Burik, J. H., Hurd, D. D., Mendizabal, A. M., Wagner, J. E., Yanovich, S., & Kernan, N. A. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.08.047 · Cited by 154
Self-citationArmand, P. A., Kim, H. T., DeAngelo, D. J., Ho, V. T., Cutler, C. S., Stone, R. M., Ritz, J., Alyea, E. P., Antin, J. H., & Soiffer, R. J. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.01.079 · Cited by 141
Self-citationMartino, R., Valcárcel, D., Brunet, S., Sureda, A. M., & Sierra, J. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705879 · Cited by 65
Flynn, C. M., Hirsch, B. A., DeFor, T. E., Barker, J. N., Miller, J. S., Wagner, J. E., Blazar, B. R., Burns, L. J., MacMillan, M. L., Arora, M., et al. (2007) · American Journal of Hematology · doi:10.1002/ajh.20989 · Cited by 60
Festuccia, M. B., Deeg, H. J., Gooley, T. A., Baker, K., Wood, B. L., Fang, M., Sandmaier, B. M., & Scott, B. L. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.03.029 · Cited by 50
Self-citation
Cited by
Döhner, H., Wei, A. H., Appelbaum, F. R., Craddock, C., DiNardo, C. D., Dombret, H., Ebert, B. L., Fenaux, P., Godley, L. A., Hasserjian, R. P., et al. (2022) · Blood · doi:10.1182/blood.2022016867 · Cited by 3,279
Hoelzer, D., Bassan, R., Dombret, H., Fielding, A., Ribera, J. M., & Buske, C. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw025 · Cited by 463
Hourigan, C. S., Dillon, L. W., Gui, G., Logan, B. R., Fei, M., Ghannam, J., Li, Y., Licon, A., Alyea, E. P., Bashey, A., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03011 · Cited by 442
Self-citationAcute myeloid leukemia: 2019 update on risk‐stratification and management
Estey, E. H. (2018) · American Journal of Hematology · doi:10.1002/ajh.25214 · Cited by 371
Thol, F., Gabdoulline, R., Liebich, A., Klement, P., Schiller, J., Kandziora, C., Hambach, L., Stadler, M., Koenecke, C., Flintrop, M., et al. (2018) · Blood · doi:10.1182/blood-2018-02-829911 · Cited by 298
Metadata
- Authors
- Scott, B. L., Pasquini, M. C., Logan, B. R., Wu, J., Devine, S. M., Porter, D. L., Maziarz, R. T., Warlick, E. D., Fernandez, H. F., Alyea, E. P., Hamadani, M., Bashey, A., Giralt, S., Geller, N. L., Leifer, E., Le-Rademacher, J., Mendizabal, A. M., Horowitz, M. M., Deeg, H. J., & Horwitz, M. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2017-04-10
- Volume
- 35
- Issue
- 11
- Pages
- 1154-1161
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2590030902
- Cited by
- 667
- References
- 26
- FWCI
- 47.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.